English
  • Ruxolitinib

    I-Ruxolitinib

    Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US)
    I-Ruxolitinib I-Myelofibrosis Novartis Julayi. 6, 2024
    uphenyoimininingwane
  • Relugolix

    I-Relugolix

    Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US)
    I-Relugolix Umdlavuza wendlala yesinye Takeda kanye ASKA Jan. 24, 2024
    uphenyoimininingwane
  • Rimegepant

    I-Rimegepant

    Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US)
    I-Rimegepant Ikhanda le-Migraine I-Biohaven Februwari 22, 2031

     

    uphenyoimininingwane
  • Relugolix 737789-87-6

    Relugolix 737789-87-6

    Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP
    I-Ribociclib CAS: 737789-87-6 I-Antineoplastic Endlini      
    uphenyoimininingwane
  • Ribociclib 1374639-75-4

    I-Ribociclib 1374639-75-4

    Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US)
    I-Ribociclib 1374639-75-4 I-HR-positive, HER2-negative Andvance ormetastaticbreast Cancers Novartis
    Ezemithi    		 Jun.27, 2028
    uphenyoimininingwane
  • Rivaroxaban

    I-Rivaroxaban

    Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP
    I-Rivaroxaban I-Anticoagulant Endlini I-TDP    
    uphenyoimininingwane
  • Rosuvastatin Calcium

    I-Rosuvastatin Calcium

    Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP
    I-Rosuvastatin Calcium I-Hypercholesterolemia Endlini/CEP 20705 √ I-CEP2015-240
    uphenyoimininingwane